Rubella immunity among pregnant women in a Canadian provincial screening program.
BACKGROUND
There are limited recent data on rubella immunity in women of childbearing age in Canada. In the present paper, the proportion of rubella seroreactivity and redundant testing (testing of women previously seropositive when tested by the same physician) in the Alberta prenatal rubella screening program were studied.


METHODS
In the present retrospective observational study, data on all specimens submitted for prenatal screening in Alberta between August 2002 and December 2005 were extracted from the Provincial Laboratory for Public Health database. The proportion of rubella screening and immunoglobulin G (IgG) seroreactivity were determined. Demographic variables were compared between rubella seroreactors and nonseroreactors. The proportion of redundant testing was determined.


RESULTS
Of 159,046 prenatal specimens, 88.3% (n=140,473) were screened for rubella immunity. In total, 8.8% of specimens tested negative for rubella IgG. Younger women (23.2% of women younger than 20 years of age versus 4.7% of women between 35 and 39 years of age; P<0.001) and women from northern Alberta (11.9% versus 8.1% [overall]; P<0.001) were significantly more likely to have seronegative specimens. Of the 20,044 women who had multiple rubella immunity screenings, 88.1% (n=17,651) had multiple positive test results. In total, 20.7% of the 42,274 specimens submitted from women with multiple screenings were deemed redundant.


CONCLUSIONS
Younger women were most likely to be seronegative for rubella. The public health significance of women entering their childbearing years with low or undetectable rubella IgG levels remains to be determined. A large number of women with documented rubella immunity were unnecessarily retested.
Kearns
Mark J
MJ
Faculty of Medicine, University of Alberta, Edmonton, Alberta;
Plitt
Sabrina S
SS
Lee
Bonita E
BE
Robinson
Joan L
JL
CMAJ. 1998 Nov 3;159(9):1091-7
9835876
Am J Public Health. 2003 Aug;93(8):1274-6
12893611
Clin Invest Med. 2005 Jun;28(3):105-11
16021983
CMAJ. 2005 Jun 21;172(13):1680-1
15967968
Epidemiol Rev. 2006;28:81-7
16775038
Can J Infect Dis. 1997 Mar;8(2):85-8
22514481
Clin Microbiol Rev. 2000 Oct;13(4):571-87
11023958
Ann Trop Paediatr. 2006 Jun;26(2):149-51
16709336
Clin Infect Dis. 2006 Nov 1;43 Suppl 3:S146-50
16998774
Can Commun Dis Rep. 2002 Sep;28 Suppl 4:1-24
12683357
Best Pract Res Clin Rheumatol. 2003 Apr;17(2):309-18
12787527
Curr Opin Immunol. 2005 Dec;17(6):616-23
16216484
Rev Panam Salud Publica. 2003 Nov;14(5):306-15
14870758
Birth Defects Res A Clin Mol Teratol. 2004 Jul;70(7):431-7
15259032